Pacira Biosciences, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Activist investor DOMA Perpetual Capital Management, holding 7.3% of Pacira BioSciences, has nominated three directors and called for the immediate replacement of CEO Frank Lee and a formal sale process for the company.
NASDAQ
SCHEDULE 13D/A: DOMA Urges Pacira Sale, Board Overhaul Amid Spending Concerns
Activist investor DOMA Perpetual Capital Management, holding 6.83% of Pacira BioSciences, announced plans to nominate three directors and called for an immediate sale of the company, citing exorbitant executive compensation and general spending.
NASDAQ
Doma Perpetual Capital Management, holding a 6.8% stake in Pacira BioSciences, is demanding the company immediately hire bankers to explore a sale, citing management underperformance and excessive spending.
NASDAQ
Doma Perpetual Capital Management and affiliated entities have disclosed a 5.7% beneficial ownership stake in Pacira BioSciences, Inc., signaling an intent to influence the company.